Skip to content
TrustList
Pi Campus logo
Investor

Pi Campus

A startup investor based in Italy that funds AI-applied companies and gives them workspace and mentoring

  • Java
  • Deep learning
  • Video
  • Commercial
  • +8 more
Pi Campus cover

About Pi Campus

Pi Campus is an investor in early-stage startups that apply artificial intelligence, with a base in Italy and an interest in companies worldwide. It aims to help young businesses challenge slow-moving, traditional industries using modern technology.

Its leadership comes from the translation company Translated. Marco Trombetti, a Translated co-founder, is chief executive of Pi Campus, and co-founder Isabelle Andrieu is chief executive of Pi School.

What Pi Campus offers

  • Early-stage investment — funds startups that use applied AI.
  • Workspace — converted villas provide offices for the companies in its network.
  • Mentorship — meetups with entrepreneurs and investors, plus events on AI and design.
  • Pi School training — engineers are trained as AI specialists while working on real problems supplied by technology companies and startups.

Who it works with

It looks for founders who bring design and emotion to technology products, and it invites talented people to introduce themselves through a short video pitch or a form.

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

Ask TrustList to introduce you to Pi Campus

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Pi Campus

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Pi Campus.

Pi Campus alternatives

Similar listings buyers compare against this one.

Network of New York City business incubators and accelerators run through NYU Tandon for early-stage ventures

Merck's corporate venture fund investing in early-stage preclinical therapeutics companies

Investment firm backing fintech companies that serve underserved people and small businesses in emerging markets

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm